Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Omnicom Group Inc. (OMC - Analyst Report) posted decent third quarter 2012 financial results with earnings per share rising roughly 2.8% year over year to 74 cents. Results surpassed the Zacks Consensus Estimate of 73 cents.
Revenue
Total revenue in the quarter climbed a meager 0.8% to settle at $3,406.6 million due to 3.4% in negative currency translation impact, more than offset by 3.5% organic revenue growth and 0.7% positive acquisition impact. Results, however, lagged behind the Zacks Consensus Estimate of $3,420 million.
From a geographical perspective, Domestic revenue accounted for 51.6% of total revenue and rose 3.2% to reach $1,758.1 million in the quarter while International revenue, representing the rest 48.4%, plummeted 1.7% to $1,648.5 million.
Based on disciplines, Advertising revenue (46.6% of total revenue) grew 5.7% to $1,587 million; CRM revenue (37.1%) increased 2.4% to $1,264.6 million; PR revenue (9.2%) was $313.8 million, down 0.3% year over year; and Specialty revenue (7.1%) was $241.2 million, down 0.3%.
Margins
Operating expenses, excluding amortization of intangibles, increased roughly 0.3% to $2,992 million and represented 87.8% of total revenue. Operating margins increased 40 basis points to 11.4% in the quarter. Net interest expense increased 26.3% to $40.3 million.
Cash Flow
During the nine months ended September 30, 2012, Omnicom spent roughly $235.4 million in dividend payments; $158.7 million on capital spending and $714.2 million on repurchasing shares. Free cash flow for the period amounted to $966 million, up 11.6% year over year.
Balance Sheet
Omnicom had a total debt balance of $4,462 million and cash and short-term investments of $1,973 million in the twelve month period ending September 30, 2012. Return on equity for the period was 15.7%.
Omnicom has a strong track record of winning new clients and receiving additional deals from the existing ones. The company’s business mix is well diversified geographically and benefits largely from the growing markets. In addition, the company’s efforts in maintaining controlled expenses and strong global reputation are commendable.
We currently maintain a Neutral recommendation on Omnicom. The stock also bears a Zacks #3 Rank (Hold).
Read the full Analyst Report on OMC